Study Design Considerations for the Evaluation of Pancreatic Enzyme Replacement Therapy (PERT) Products in People with Cystic Fibrosis: An Update.
- DOI
- 10.1016/j.clinthera.2026.04.021
- Published
- 2026 Jul
- Container
- Clinical therapeutics
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.clinthera.2026.04.021,
title = {Study Design Considerations for the Evaluation of Pancreatic Enzyme Replacement Therapy (PERT) Products in People with Cystic Fibrosis: An Update.},
author = {Konstan MW and Ramsey ML and Sathe M and Freeman AJ and Freedman SD and Schwarzenberg SJ and O'Rourke C and Onchiri FM and Setiawan L and Pilewski JM and Mayer-Hamblett N},
year = {2026},
journal = {Clinical therapeutics},
doi = {10.1016/j.clinthera.2026.04.021},
url = {https://doi.org/10.1016/j.clinthera.2026.04.021}
}RIS
TY - JOUR TI - Study Design Considerations for the Evaluation of Pancreatic Enzyme Replacement Therapy (PERT) Products in People with Cystic Fibrosis: An Update. AU - Konstan MW AU - Ramsey ML AU - Sathe M AU - Freeman AJ AU - Freedman SD AU - Schwarzenberg SJ AU - O'Rourke C AU - Onchiri FM AU - Setiawan L AU - Pilewski JM AU - Mayer-Hamblett N PY - 2026 JO - Clinical therapeutics DO - 10.1016/j.clinthera.2026.04.021 UR - https://doi.org/10.1016/j.clinthera.2026.04.021 ER -
APA
MW, K., ML, R., M, S., AJ, F., SD, F., SJ, S., C, O., FM, O., L, S., JM, P., & N, M. (2026). Study Design Considerations for the Evaluation of Pancreatic Enzyme Replacement Therapy (PERT) Products in People with Cystic Fibrosis: An Update.. Clinical therapeutics. https://doi.org/10.1016/j.clinthera.2026.04.021
Source records
- pubmed · retrieved 2026-09-25T21:03:17.617Z